000 01308 a2200373 4500
005 20250513110423.0
264 0 _c19970326
008 199703s 0 0 eng d
022 _a0387-7604
024 7 _a10.1016/s0387-7604(96)00045-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZafeiriou, D I
245 0 0 _aAdrenocorticotropic hormone and vigabatrin treatment of children with infantile spasms underlying cerebral palsy.
_h[electronic resource]
260 _bBrain & development
_c
300 _a450-2 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdrenocorticotropic Hormone
_xtherapeutic use
650 0 4 _aAnticonvulsants
_xtherapeutic use
650 0 4 _aCerebral Palsy
_xcomplications
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aMale
650 0 4 _aMotor Activity
_xdrug effects
650 0 4 _aPrognosis
650 0 4 _aSpasms, Infantile
_xdrug therapy
650 0 4 _aVigabatrin
650 0 4 _agamma-Aminobutyric Acid
_xanalogs & derivatives
700 1 _aKontopoulos, E E
700 1 _aTsikoulas, I G
773 0 _tBrain & development
_gvol. 18
_gno. 6
_gp. 450-2
856 4 0 _uhttps://doi.org/10.1016/s0387-7604(96)00045-9
_zAvailable from publisher's website
999 _c8972330
_d8972330